ELII: Preclinical Development of m 102.4 , a Human Anti-Hendra and Nipah Antibody

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/14 → 12/31/17

Funding

  • Profectus BioSciences, Inc.: $263,543.93